An Observational Study Into the Variety of Electrocardiographic Responses to an Ajmaline Provocation in a Healthy Subjects. What Are the Genetic and Structural Variations Dictating This Response ?

Who is this study for? Patients with Brugada Syndrome
What treatments are being studied? Ajmaline
Status: Unknown status
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

Standard, high lead and sodium channel provoked electrocardiograms of a healthy volunteers will be performed to observe the various ECG changes. Participants will the undergo detailed imaging with cardiac magnetic resonance imaging and deep genotyping to identify structural or genetic variants which might dictate the electrocardiographic patterns at rest and with sodium channel provocation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: Accepts Healthy Volunteers
View:

• Asymptomatic healthy Volunteers

Locations
Other Locations
United Kingdom
St George's University Of London
London
Time Frame
Start Date: October 22, 2017
Completion Date: December 2019
Participants
Target number of participants: 100
Treatments
Experimental: Healthy Volunteers
Once screened by the investigators, the participants will undergo ajmaline provocation, cardiac magnetic resonance imaging and genotype evaluation
Sponsors
Leads: St George's, University of London

This content was sourced from clinicaltrials.gov

Similar Clinical Trials